LENZING AG (LEN.DE) Stock Fundamental Analysis
FRA:LEN - AT0000644505 - Common Stock
28.3 EUR
+0.3 (+1.07%)
LEN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. LEN has a bad profitability rating. Also its financial health evaluation is rather negative. LEN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
LEN had negative earnings in the past year.
LEN had a positive operating cash flow in the past year.
In multiple years LEN reported negative net income over the last 5 years.
LEN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
LEN has a Return On Assets of -2.41%. This is in the lower half of the industry: LEN underperforms 66.67% of its industry peers.
LEN's Return On Equity of -9.59% is on the low side compared to the rest of the industry. LEN is outperformed by 71.01% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.19%, LEN is in line with its industry, outperforming 50.72% of the companies in the same industry.
LEN had an Average Return On Invested Capital over the past 3 years of 1.29%. This is significantly below the industry average of 6.71%.
The last Return On Invested Capital (3.19%) for LEN is above the 3 year average (1.29%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.41% | ||
| ROE | -9.59% | ||
| ROIC | 3.19% |
ROA(3y)-5.64%
ROA(5y)-2.94%
ROE(3y)-20.41%
ROE(5y)-11%
ROIC(3y)1.29%
ROIC(5y)1.63%
1.3 Margins
With a Operating Margin value of 6.63%, LEN perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
In the last couple of years the Operating Margin of LEN has declined.
Looking at the Gross Margin, with a value of 20.63%, LEN is doing worse than 71.01% of the companies in the same industry.
In the last couple of years the Gross Margin of LEN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.63% | ||
| PM (TTM) | N/A | ||
| GM | 20.63% |
OM growth 3Y-21.19%
OM growth 5Y-11.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.92%
GM growth 5Y-14.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LEN is destroying value.
Compared to 1 year ago, LEN has about the same amount of shares outstanding.
LEN has more shares outstanding than it did 5 years ago.
LEN has a better debt/assets ratio than last year.
2.2 Solvency
LEN has an Altman-Z score of 1.24. This is a bad value and indicates that LEN is not financially healthy and even has some risk of bankruptcy.
LEN has a Altman-Z score of 1.24. This is in the lower half of the industry: LEN underperforms 75.36% of its industry peers.
LEN has a debt to FCF ratio of 20.42. This is a negative value and a sign of low solvency as LEN would need 20.42 years to pay back of all of its debts.
LEN has a Debt to FCF ratio (20.42) which is in line with its industry peers.
A Debt/Equity ratio of 1.59 is on the high side and indicates that LEN has dependencies on debt financing.
LEN has a worse Debt to Equity ratio (1.59) than 88.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.59 | ||
| Debt/FCF | 20.42 | ||
| Altman-Z | 1.24 |
ROIC/WACC0.51
WACC6.31%
2.3 Liquidity
A Current Ratio of 1.82 indicates that LEN should not have too much problems paying its short term obligations.
LEN has a Current ratio (1.82) which is comparable to the rest of the industry.
LEN has a Quick Ratio of 1.21. This is a normal value and indicates that LEN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.21, LEN is in line with its industry, outperforming 57.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.21 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 80.17% over the past year.
Looking at the last year, LEN shows a small growth in Revenue. The Revenue has grown by 4.37% in the last year.
The Revenue has been growing slightly by 4.82% on average over the past years.
EPS 1Y (TTM)80.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.99%
Revenue 1Y (TTM)4.37%
Revenue growth 3Y6.67%
Revenue growth 5Y4.82%
Sales Q2Q%-0.21%
3.2 Future
LEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.10% yearly.
Based on estimates for the next years, LEN will show a small growth in Revenue. The Revenue will grow by 2.54% on average per year.
EPS Next Y-17.9%
EPS Next 2Y34.7%
EPS Next 3Y38.41%
EPS Next 5Y44.1%
Revenue Next Year3.8%
Revenue Next 2Y3.4%
Revenue Next 3Y3.22%
Revenue Next 5Y2.54%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LEN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LEN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LEN is valued cheaply inside the industry as 94.20% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, LEN is valued cheaply inside the industry as 92.75% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.61 | ||
| EV/EBITDA | 4.97 |
4.3 Compensation for Growth
LEN's earnings are expected to grow with 38.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.7%
EPS Next 3Y38.41%
5. Dividend
5.1 Amount
LEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:LEN (8/25/2025, 7:00:00 PM)
28.3
+0.3 (+1.07%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners17.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.09B
Analysts49.09
Price Target28.35 (0.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.74
Dividend Growth(5Y)-31.68%
DP-23.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.59%
PT rev (3m)-14.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2689.43%
EPS NY rev (3m)-2689.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.25%
Revenue NY rev (3m)-4.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.41 | ||
| P/FCF | 9.61 | ||
| P/OCF | 4.05 | ||
| P/B | 0.87 | ||
| P/tB | 0.89 | ||
| EV/EBITDA | 4.97 |
EPS(TTM)-3.12
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)2.95
FCFY10.41%
OCF(TTM)6.99
OCFY24.69%
SpS69.76
BVpS32.5
TBVpS31.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.41% | ||
| ROE | -9.59% | ||
| ROCE | 4.53% | ||
| ROIC | 3.19% | ||
| ROICexc | 4.04% | ||
| ROICexgc | 4.07% | ||
| OM | 6.63% | ||
| PM (TTM) | N/A | ||
| GM | 20.63% | ||
| FCFM | 4.22% |
ROA(3y)-5.64%
ROA(5y)-2.94%
ROE(3y)-20.41%
ROE(5y)-11%
ROIC(3y)1.29%
ROIC(5y)1.63%
ROICexc(3y)1.51%
ROICexc(5y)2.07%
ROICexgc(3y)1.52%
ROICexgc(5y)2.09%
ROCE(3y)1.84%
ROCE(5y)2.31%
ROICexcg growth 3Y-16.94%
ROICexcg growth 5Y-17.21%
ROICexc growth 3Y-16.83%
ROICexc growth 5Y-17.09%
OM growth 3Y-21.19%
OM growth 5Y-11.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.92%
GM growth 5Y-14.28%
F-Score6
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.59 | ||
| Debt/FCF | 20.42 | ||
| Debt/EBITDA | 3.98 | ||
| Cap/Depr | 48.34% | ||
| Cap/Sales | 5.79% | ||
| Interest Coverage | 1.71 | ||
| Cash Conversion | 53.81% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.21 | ||
| Altman-Z | 1.24 |
F-Score6
WACC6.31%
ROIC/WACC0.51
Cap/Depr(3y)130.66%
Cap/Depr(5y)264.56%
Cap/Sales(3y)14.58%
Cap/Sales(5y)24.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.99%
EPS Next Y-17.9%
EPS Next 2Y34.7%
EPS Next 3Y38.41%
EPS Next 5Y44.1%
Revenue 1Y (TTM)4.37%
Revenue growth 3Y6.67%
Revenue growth 5Y4.82%
Sales Q2Q%-0.21%
Revenue Next Year3.8%
Revenue Next 2Y3.4%
Revenue Next 3Y3.22%
Revenue Next 5Y2.54%
EBIT growth 1Y140.1%
EBIT growth 3Y-15.93%
EBIT growth 5Y-7.56%
EBIT Next Year505.76%
EBIT Next 3Y92.08%
EBIT Next 5Y68.88%
FCF growth 1Y121.3%
FCF growth 3YN/A
FCF growth 5Y207.34%
OCF growth 1Y407.83%
OCF growth 3Y-6.46%
OCF growth 5Y5.68%